Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer

Figure 1

ROC curve analyses of training data set ( n= 230) (A and B) and validation set ( n= 150) (C and D). Panel A shows ROC curves for prediction of LC using multiple logistic regression weightings for each individual biomarker and a model combining all 4 biomarkers. The AUC values are 0.60, 0.79, 0.70, 0.69, and 0.83 for NY-ESO-1, CEA, CA125, CYFRA 21–1, and the combined panel, respectively; Panel B is a ROC curve generated from the 4-biomarker panel using the MoM scoring method (AUC value = 0.81); Panel C shows a ROC curve of the validation set for prediction of LC using the MLR method (AUC = 0.82), and Panel D shows the same data using MoM transformation (AUC = 0.85).

Back to article page